MEVIS MEDICAL SOL.NA O.N.
MEVIS MEDICAL SOL.NA O.N./ DE000A0LBFE4 /
M3V
|
10/5/2022 5:36:00 PM
|
Chg.
-0.400
|
Volume |
Bid10/5/2022 |
Ask10/5/2022 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
33.600EUR
|
-1.18%
|
38
Turnover: 1,270.800 |
-Bid Size: - |
-Ask Size: - |
60.79 mill.EUR |
0.00% |
13.37 |
Fundamentals
| |
FY 2021 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
2.50 EUR |
-20.31% |
| EPS Diluted: |
2.50 EUR |
-20.31% |
| Revenues per Share: |
8.90 EUR |
-5.26% |
| Book Value per Share: |
9.78 EUR |
0.00% |
| Cash Flow per Share: |
5.00 EUR |
213.79% |
| Dividend per Share: |
0.00 EUR |
- |
| Total |
in mill. |
|
| Revenues: |
16.20 EUR |
-5.26% |
| Net Income: |
4.50 EUR |
-21.05% |
| Operating Cash Flow: |
9.10 EUR |
- |
| Cash and Cash Equivalents: |
7.60 EUR |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
13.37 |
13.05 |
| P/S Ratio: |
3.75 |
3.66 |
| P/BV ratio: |
3.42 |
3.33 |
| P/CF Ratio: |
6.68 |
6.52 |
| PEG: |
-0.66 |
-0.64 |
| Earnings Yield: |
7.48% |
7.66% |
| Dividend Yield: |
0.00% |
0.00% |
| Market Capitalization |
|
| Market Capitalization: |
60.79 mill. EUR |
59.33 mill. EUR |
| Free Float Market Cap.: |
8.37 mill. EUR |
8.17 mill. EUR |
| Market Cap. / Employee: |
584,500 EUR |
570,500 EUR |
| Shares Outstanding: |
1.82 mill. |
|
Profitability
| Gross Profit Margin: |
42.59% |
| EBIT Margin: |
27.78% |
| Net Profit Margin: |
27.78% |
| Return on Equity: |
25.28% |
| Return on Assets: |
16.36% |
Financial Strength
| Liquidity I / Cash Ratio: |
- |
| Liquidity II / Quick Ratio: |
- |
| Liquidity III / Current Ratio: |
- |
| Debt / Equity Ratio: |
54.49% |
| Dynam. Debt / Equity Ratio: |
106.59% |
Efficiency
| Employees: |
104 |
| Personal Expenses / Employee: |
85,576.92 EUR |
| Revenues / Employee: |
155,769.23 EUR |
| Net Income / Employee: |
43,269.23 EUR |
| Total Assets / Employee: |
264,423.08 EUR |
| * Fiscal Year End: |
9/30/2021 |